We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Exchange Traded Fund (ETF): Archive
Will a Clinton Presidency Spell Doom for Pharma ETFs?
by Zacks Equity Research
Ongoing drug pricing controversy continues to weigh on the industry but there are several reasons to take a look at the beaten down ETFs.
XPHNegative Net Change PPHNegative Net Change PJPNegative Net Change